Medicap Healthcare Ltd Eyes Rs 240 Crore Through IPO for Expansion

Medicap Healthcare Ltd has filed draft papers for an IPO aiming to raise Rs 240 crore. The entire offering is a fresh equity issue with no sale offer. The funds will support plant and equipment acquisitions, debt payments, and corporate purposes. Aryaman Financial Services oversees the issue.


Devdiscourse News Desk | New Delhi | Updated: 23-09-2025 17:34 IST | Created: 23-09-2025 17:34 IST
Medicap Healthcare Ltd Eyes Rs 240 Crore Through IPO for Expansion
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

Medicap Healthcare Ltd has submitted draft papers to the Securities and Exchange Board of India (SEBI) to garner Rs 240 crore via an initial public offering (IPO). The IPO, entirely a fresh equity issue, omits an offer for sale (OFS) segment, the draft red herring prospectus reveals.

The company is targeting a Rs 48 crore raise in a pre-IPO placement, which would correspondingly slash the fresh issue's magnitude. The IPO proceeds are earmarked for purchasing machinery for its manufacturing unit, debt settlement for KASR Healthcare, a subsidiary, and other corporate needs.

Situated in Vadodara, Medicap Healthcare produces critical packaging for the pharmaceutical industry. The IPO marks the firm's plans to upscale capacity and fortify its financial structure. Aryaman Financial Services is the lead manager for the public issue.

(With inputs from agencies.)

Give Feedback